Misako Nagasaka
Misako Nagasaka, MD, PhD is an Associate Clinical Professor in Thoracic Oncology for the Division of Hematology/Oncology, Department of Medicine at the University of California Irvine. She completed her residency in Internal Medicine at Beth Israel Medical Center in NYC and fellowship at Karmanos Cancer Institute in Detroit. Her clinical and research interests are in molecular targeted therapy and immunotherapy in thoracic malignancies, with a special focus in medical ethics. She has more than 90 publications, abstracts and book chapters including the New England Journal of Medicine, the Journal of Clinical Oncology and the Journal of Thoracic Oncology. She has experience serving as the site principal investigator (PI) for over 20 interventional trials (and has served as a sub-investigator for a number of studies) and enjoys collaborating with other researchers across the country and around the world.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AstraZenecaDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Daiichi SankyoDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:NovartisDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:EMD SeronoDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:PfizerDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:LillyDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:GenentechDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:MiratiDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Caris Life SciencesDate added:11/09/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:TakedaDate added:11/09/2022